Clinical tumour sequencing for precision oncology: time for a universal strategy.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 30030494.
- Also identified by DOI 10.1038/s41568-018-0043-2 and PMC identifier 6618305.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Routine, comprehensive molecular characterization of patient tumours has the potential to accelerate therapeutic advances and inform cancer biology. Here, we describe insights from the implementation of an enterprise-wide, prospective clinical sequencing strategy at an academic cancer centre.
Medical subject headings
- Neoplasms
- Precision Medicine